Exosome Technologies Market 2021-2030 With Strategic Trends Growth, Demand & Future Potential Of Industry

Use of EV-Viral Interplay for Development of Antiviral Drugs for Evolving Coronavirus Strains

The outbreak of severe acute respiratory syndrome β-coronavirus 2 (SARS-CoV-2) has led to a potential long-lasting global health crisis. Thus, extracellular vesicles (EVs) are emerging as a possible solution for improving lung immunity. Companies in the exosome technologies market are increasing their research for conducting the pathogenesis of various lung diseases and viral infections in order to keep economies running during the COVID-19 outbreak.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111822

New coronavirus strains are creating revenue opportunities for companies in the exosome technologies market, as EVs share structural similarities to viruses. Such an EV-viral interplay holds promising potentials for the development of antiviral drugs and vaccine development. Mesenchymal stem cell-derived EVs are being investigated for the treatment of the novel infection.

Appropriate Combination of Several Methods Help Improve Limitations of Exosomes

Compared to synthetic carriers such as nanoparticles and liposomes, the heterogeneity and endogeneity of exosomes demonstrate unique advantages in disease diagnosis and treatment. However, storage stability, low purity, and weak targeting of exosomes are limiting its clinical applications. Hence, companies in the exosome technologies market are increasing their R&D to establish the appropriate combination of several methods to extract and purify exosomes to effectively improve over its limitations.

The exosome technologies market is projected to expand at an astonishing CAGR of 24.2% during the assessment period. There is a need to optimize and improvise the exosome loading capacity and methods for enhancing targeting drugs. Companies are increasing efforts to conduct all-round and multi-field researches to analyze the biological functions of exosomes.

Transdermal Delivery of ASC-Exosomes Facilitates Skin Brightening Through Cosmeceuticals

The cellular intelligence communication is gaining prominence in the field of cosmetics. Exosomes derived from human adipose tissue-derived mesenchymal stem/stromal cells (ASC-exosomes) are being investigated for minimizing skin pigmentation. As such, there is a need to improve the transdermal delivery of ASC-exosomes to enable skin brightening through cosmeceuticals in the exosome technologies market.

There is a high prevalence of individuals suffering from hyperpigmentation or hypermelanosis, which is a skin disorder resulting in excessive accumulation of melanin in the skin leaving the skin aesthetically undesirable. Such skin disorders are acting as a key driver for the exosome technologies market. Exosomes derived from mesenchymal stem/stromal cell (MSC) cultures are a promising next-generation cell-free therapeutic option.

Exosomes Regulate CVD Progression via Exchange of Signal Molecules

Exosomes, also known as extracellular vesicles with a lipid bilayer membrane of endosomal origin have become the focus of a large body of research in cardiovascular diseases (CVD) for companies in the exosome technologies market. These EVs serve as carriers for signal molecules responsible for intracellular and inter-organ communication underlying CVD pathophysiology. Moreover, they help to overcome limitations of the stem cell therapy, since exosomes released by progenitor cells are bioactive and act as key mediators for the stem cell therapy of CVD.

Exosomes play a critical role in cardiovascular pathophysiology, as they help to regulate CVD progression via transport and exchange of signal molecules. For instance, exosomes released by cardiac fibroblasts rescue cardiomyocytes from ischemia-reperfusion injury.

Exosomes Possess Huge Potential in Field of Cancer Immunotherapy

Cell-derived nanovesicles also known as exosomes have the potential to increase clinical outcomes in cancer immunotherapy, owing to their advantageous immunogenicity and molecular transfer function. Companies in the exosome technologies market are adopting proprietary manufacturing platforms to develop EVs that help to regulate immune responses. They are boosting their production capabilities to develop exosomes that are derived from tumor cells and immune cells, which exhibit unique composition profiles that are directly linked with anti-cancer immunotherapy.

Exosomes hold promising potentials to deliver their cargoes to targeted cells and influence the phenotype and immune-regulation functions of targeted cells. Thus, companies in the exosome technologies market are gaining awareness that exosomes have huge potential in the field of cancer immunotherapy.

Analysts’ Viewpoint

The ever-evolving COVID-19 strains have plunged pharmaceutical and biotech companies to accelerate vaccine and antiviral therapeutics to capitalize on incremental opportunities. The exosome technologies market is projected to surpass US$ 300 Mn by the end of 2031. However, secretion mechanism and fusion mechanism of exosomes are still unclear. Hence, companies should conduct all-round multi-field researches to analyze its biological functions and lay the foundation for subsequent clinical testing, pharmacokinetics, and toxicology research to enable targeted drug delivery in patients. They should develop exosomes that can be used to produce effective cancer vaccines and targeted antigens.

View full report@ https://qyresearchmedical.com/report/exosome-technologies-market-exosome-type-loaded-cargo-and-non-cargo-cell-source-hek293-mscs-platelets-erythrocytes-natural-killer-cells-nks-and-others-indication-therapeutics-and-diagnostics-and-end-us-2021-2030/111822

Exosome Technologies Market: Overview

This report analyzes the current scenario and future prospects of the global exosome technologies market. Rise in prevalence of chronic diseases, increase in awareness about exosome technologies, and government initiatives are projected to boost the growth of the global exosome technologies market.

The report includes an elaborate executive summary, which provides a snapshot of various segments of the global exosome technologies market. It also provides information and data analysis of the exosome technologies market about segments based on exosome type, cell source, indication, end user, and region.

The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the global exosome technologies market

The report includes company profiles, which provide information about their business, product portfolios, and competition landscape in the global exosome technologies market

The report on the exosome technologies market offers market attractiveness analysis of regions and segments

The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the global exosome technologies market. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global exosome technologies market.

Exosome Technologies Market: Key Segments

In terms of exosome type, the global exosome technologies market has been classified into loaded cargo and non-cargo. The loaded cargo segment has been split into peptide, siRNA, mRNA, miRNA, protein, chemical, and others. The loaded cargo segment accounted for major share of the market in 2020, and the trend is anticipated to continue during the forecast period. Increase in specificity of exosome cargo in relation to the cell of origin and surge in the number of applications of loaded cargo are expected to augment the segment.

Based on cell source, the global exosome technologies market has been categorized into HEK293, MSCs, platelets, erythrocytes, natural killer cells (NKs), and others. The MSCs segment dominated the market in 2020. Exosomes derived from MSCs have both self-renewal capabilities and differentiation potentials. It can be derived from a range of tissues and body fluids, such as adipose tissue, bone marrow (BM), dental pulp, synovial fluid (SF), amniotic fluid (AF), placenta (PL), umbilical cord (UC), umbilical cord blood (UCB).

In terms of indication, the global exosome technologies market has been bifurcated into therapeutics and diagnostics. Promising future of exosomes in therapeutic applications is likely to drive the therapeutics segment.

Based on end user, the global exosome technologies market has been divided into healthcare providers, pharmaceutical & biotechnology companies, and others. The healthcare providers segment accounted for major share of the market. Increase in geriatric population with various diseases is projected to propel the segment.

Market size and forecast for each of these segments have been provided from 2015 to 2031. The CAGR of respective segments has also been provided from 2021 to 2031, considering 2020 as the base year.

Exosome Technologies Market: Regional Outlook

In terms of region, the global exosome technologies market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.

The exosome technologies market report provides size and forecast for each region and country/sub-region from 2015 to 2031. The CAGR for each of these regions and countries has also been provided for the forecast period from 2021 to 2031. The exosome technologies market study also covers the competitive scenario in these regions.

Companies Covered in Exosome Technologies Market Report

Key players in the global exosome technologies market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111822/2900

Major companies profiled in the exosome technologies market report are

  • Aegle Therapeutics
  • Anjarium Biosciences
  • Aruna Biomedical
  • Carmine Therapeutics
  • Evox Therapeutics
  • Exosome Diagnostics, Inc.
  • ExonanoRNA LLC., among others

Key Questions Answered in Exosome Technologies Market Report

  • What is the revenue forecast for the global exosome technologies market in terms of revenue for the period 2021–2031?
  • How would various dynamics such as drivers, restraints, opportunities, and trends affect the market?
  • What is the market size and estimation for the exosome technologies market across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa?
  • Which regional market is poised to expand at a significant CAGR during the forecast period?
  • Which product segment is projected to generate considerable revenue in 2031 and which application segment will register the fastest CAGR during the forecast period?

Exosome Technologies Market – Segmentation

Exosome Type

  • Loaded Cargo
  • Peptide
  • siRNA
  • mRNA
  • Protein
  • Chemical
  • Others
  • Non-cargo

Cell Source

  • HEK293
  • MSCs
  • Platelets
  • Erythrocytes
  • Natural Killer Cells (NKs)
  • Others


  • Therapeutics
  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Cosmetics
  • Others
  • Diagnostics

End User

  • Healthcare Providers
  • Pharmaceutical & Biotechnology Companies
  • Others


  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Exosome Technologies Market

4. Market Overview

4.1. Introduction

4.1.1. Exosome Type Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Exosome Technologies Market Analysis and Forecast, 2015–2030

5. Key Insights

5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

5.2. Key Industry Events (mergers, acquisitions, partnerships, etc.)

5.3. Pipeline Analysis

5.4. Technological Advancement

5.5. Licensing deals (IP portfolio/patent/status of – Codiak, Ciloa SAS, Evox, and ExonanoRNA LLC)

6. Global Exosome Technologies Market Analysis and Forecast, by Exosome Type 

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Exosome Type, 2015–2030

6.3.1. Loaded Cargo Peptide siRNA mRNA miRNA Protein Chemical Others

6.3.2. Non-cargo

6.4. Market Attractiveness Analysis, by Exosome Type

7. Global Exosome Technologies Market Analysis and Forecast, by Cell Source

7.1. Introduction & Definition

7.1.1. Key Findings / Developments

7.2. Market Value Forecast, by Cell Source, 2015–2030

7.2.1. HEK293

7.2.2. MSCs

7.2.3. Platelets

7.2.4. Erythrocytes

7.2.5. Natural Killer Cells (NKs)

7.2.6. Others

7.3. Market Attractiveness Analysis, by Cell Source

8. Global Exosome Technologies Market Analysis and Forecast, by Indication

8.1. Introduction & Definition

8.1.1. Key Findings / Developments

8.2. Market Value Forecast, by Indication, 2015–2030

8.2.1. Therapeutics Oncology Neurodegenerative Diseases Cardiovascular Diseases Infectious Diseases Cosmetics Others

8.2.2. Diagnostics

8.3. Market Attractiveness Analysis, by Indication

9. Global Exosome Technologies Market Analysis and Forecast, by End-user

9.1. Introduction & Definition

9.1.1. Key Findings / Developments

9.2. Market Value Forecast, by End-user, 2015–2030

9.2.1. Health Care Providers

9.2.2. Pharmaceutical & Biotechnology Companies

9.2.3. Others

9.3. Market Attractiveness Analysis, by End-user

10. Global Exosome Technologies Market Analysis and Forecast, by Region


Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111822/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us: